GMC calls for a uniform prescribing system

Prescribing errors in hospitals could be reduced if a standardised prescription chart was introduced in all UK hospitals, says the GMC. Nearly one in...

Database launched to prioritise cancer research

NICE has launched a new database that will help with the identification and prioritisation of future cancer research across Europe. The Database of Cancer...

Business Edge undergoes makeover

Training and development specialists Business Edge Solutions and Training have undertaken a makeover to increase their appeal to customers, including the addition of...

From care home to home care

A Bill proposing measures to help people with high care needs remain independent for longer has been introduced to Parliament by Health Secretary Andy...

‘Fly paper’ for tumour cells in blood

An innovative new device developed by US researchers at UCLA can catch cancer cells in the blood that have broken off from a tumour....

Changes to EU control of pharma policy

European Commission President José Manuel Barroso has decided to transfer responsibility for pharmaceuticals to the new health commissioner following significant lobbying by health NGOs....

EC extends Angiox use

The Medicines Company has received European approval for an extension to the licensed use of its anticoagulant Angiox (bivalirudin). The drug is now approved...

EU positive opinion for silodosin

The CHMP has decided in favour of Almirall’s silodosin, recommending the granting of marketing authorisations for the medicinal products Urorec and Silodyx hard capsules...

NHS challenged over ‘shocking’ cancer statistics

The Cancer Reform Strategy’s second annual report has highlighted large regional variations in cancer patient survival rates and access to services. The figures are...

WHO proposes changes to HIV treatment

The new recommendations were published on 30 November 2009, the eve of World AIDS Day. Earlier initiation of antiretroviral therapy (ART) is proposed for...

Latest articles

Woman undergoing breast checks with doctor to show NICE recommends new early breast cancer treatment

Novartis’ Kisqali® shows overall survival benefit in advanced breast cancer

Novartis has announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, reinforcing the overall survival (OS) benefit of Kisqali®...
Image of a rocket launching from a laptop keyboard to show Pf Webinars: Adopting Agile for more effective cross-functional marketing teamwork

Pf Webinar: Adopting Agile in pharma for more effective cross-functional marketing teamwork

Pf is proud to announce the second instalment of the FREE webinar series with Triducive. This webinar focuses on Agile and how it can...
Doctor writing notes to show New Patient Recruitment Centres for late-phase clinical research

New Patient Recruitment Centres for late-phase clinical research

NHS patients will benefit from easier access to clinical research opportunities, following a £7m government investment to launch five new regional Patient Recruitment Centres...

Popular articles

Image of a hand holding a torch to show Kate Bingham appointed Chair of UK Vaccine Taskforce

Kate Bingham appointed Chair of UK Vaccine Taskforce

Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
Woman undergoing breast checks with doctor to show NICE recommends new early breast cancer treatment

Novartis’ Kisqali® shows overall survival benefit in advanced breast cancer

Novartis has announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, reinforcing the overall survival (OS) benefit of Kisqali®...
Image of a robot holding a medical bag to show Digital transformation in the NHS

Digital transformation in the NHS

A new report by the National Audit Office (NAO) on digital transformation in the NHS has found that recent investment in digital transformation has...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Image of a medical professional in PPE with medical equipment to show BIVDA comments on Roche COVID-19 antibody test authorisation in England

BIVDA comments on Roche COVID-19 antibody test authorisation

The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription